We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Dual anti-angiogenic and anti-metastatic activity of myriocin synergistically enhances the anti-tumor activity of cisplatin

    Purpose

    Tumor microenvironment consists of various kind of cells, forming complex interactions and signal transductions for tumor growth. Due to this...

    Ji-Hak Jeong, Uttam Ojha, ... You Mie Lee in Cellular Oncology
    Article 04 November 2022
  2. Paeonol upregulates expression of tumor suppressors TNNC1 and SCARA5, exerting anti-tumor activity in non-small cell lung cancer cells

    Paeonol, a naturally bioactive phenolic ingredient predominantly isolated from Paeonia suffruticosa , has recently garnered significant interest as an...

    Chongnan Zhang, **g Zhang, Kai Guo in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 24 January 2024
  3. Immunoglobulin superfamily 6 is a molecule involved in the anti-tumor activity of macrophages in lung adenocarcinoma

    Background

    Immunoglobulin superfamily 6 (IGSF6) is a novel member of the immunoglobulin superfamily and has been implicated in various diseases....

    Qisi Zheng, Ting Wang, ... **nyu Tian in BMC Cancer
    Article Open access 30 November 2023
  4. HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo

    Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. Current treatment options for GBM include surgical...

    Xueying Li, Lifen Zhao, ... Nianzhu Zhang in Genes & Immunity
    Article Open access 03 May 2024
  5. Selective anti-tumor activity of glutathione-responsive abasic site trap** agent in anaplastic thyroid carcinoma

    Anaplastic thyroid carcinoma (ATC) is a rare but highly aggressive thyroid cancer with poor prognosis. Killing cancer cells by inducing DNA damage or...

    **yan Chai, Mengxue Su, ... Zhaowei Meng in BMC Cancer
    Article Open access 08 July 2024
  6. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro

    Background

    Glioblastoma represents a brain tumor with a notoriously poor prognosis. First-line therapy may include adjunctive Tumor Treating Fields...

    Qiyu Cao, Annika Hajosch, ... Georg Karpel-Massler in British Journal of Cancer
    Article Open access 23 February 2024
  7. Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms

    Background

    Gastric-cancer is a heterogeneous type of neoplastic disease and it lacks appropriate therapeutic options. There is an urgent need for the...

    Luca Guarrera, Mami Kurosaki, ... Enrico Garattini in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 November 2023
  8. Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

    Regulatory T cells (Tregs) expressing the transcription factor FoxP3 are essential for maintaining immunological balance and are a significant...

    Yu Li, Cangang Zhang, ... Peng Luo in Journal of Translational Medicine
    Article Open access 20 March 2024
  9. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade

    Background

    Tumor regression following immune checkpoint blockade (ICB) is often associated with immune-related adverse events (irAEs), marked by...

    Shuming Chen, Tracee L. McMiller, ... Suzanne L. Topalian in Journal of Translational Medicine
    Article Open access 05 March 2024
  10. Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapy

    Background

    Zinc oxide nanoparticles (ZnONPs) have impressively shown their efficacy in targeting and therapy of cancer. The present research was...

    Soha Gomaa, Mohamed Nassef, ... Asmaa Abdel-Ghany in BMC Cancer
    Article Open access 04 January 2024
  11. Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer

    Background

    Breast cancer is the most prevalent female tumor, of which triple-negative breast cancer (TNBC) accounts for about 15%. Characterized by...

    Mei Zhao, Panling Xu, ... ** Li in Cancer Cell International
    Article Open access 14 February 2024
  12. Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity

    Necroptosis is a form of regulated necrosis and is executed by MLKL when MLKL is engaged in triggering the rupture of cell plasma membrane. MLKL...

    Zhaoshan Liu, Swati Choksi, ... Zheng-gang Liu in Breast Cancer Research
    Article Open access 26 January 2023
  13. Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC

    Background

    Chimeric antigen receptor (CAR)-T cells can induce powerful immune responses in patients with hematological malignancies but have had...

    Micaela Harrasser, Satyen Harish Gohil, ... Amit Chunilal Nathwani in Breast Cancer Research
    Article Open access 03 June 2022
  14. A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor

    Purpose

    Natural materials have been extensively studied for oral drug delivery due to their biodegradability and other unique properties. In the...

    Farah Rehan, Md. Emranul Karim, ... Ezharul Hoque Chowdhury in Journal of Pharmaceutical Investigation
    Article Open access 10 September 2022
  15. SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancer

    Anti-programmed cell death 1 (aPD1) therapy has yielded limited success in patients with colorectal cancer (CRC). Syndecan binding protein (SDCBP),...

    Jiahua Yu, Shijun Yu, ... Yandong Li in Cancer Gene Therapy
    Article 30 March 2024
  16. Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity

    Background

    Aberrant sialoglycans on the surface of tumor cells shield potential tumor antigen epitopes, escape recognition, and suppress activation of...

    Jianmei Huang, Meiying Li, ... Guonan Zhang in Journal of Translational Medicine
    Article Open access 31 October 2022
  17. Gaseous nitric oxide tumor ablation induces an anti-tumor abscopal effect

    Background

    In-situ tumor ablation provides the immune system with the appropriate antigens to induce anti-tumor immunity. Here, we present an...

    Hila Confino, Frederick M. Dirbas, ... Ido Wolf in Cancer Cell International
    Article Open access 13 December 2022
  18. Fasting mimicking diet inhibits tumor-associated macrophage survival and pro-tumor function in hypoxia: implications for combination therapy with anti-angiogenic agent

    Background

    Recent research shows that tumor-associated macrophages (TAMs) are the primary consumers of glucose in tumor tissue, surpassing that of...

    Lei Wang, Yu-jie Wang, ... Yong-fang Yuan in Journal of Translational Medicine
    Article Open access 26 October 2023
  19. Phosphatidylserine and/or Sialic Acid Modified Liposomes Increase Uptake by Tumor-associated Macrophages and Enhance the Anti-tumor Effect

    DOX liposomes have better therapeutic effects and lower toxic side effects. The targeting ability of liposomes is one of the key factors affecting...

    Zihan Xu, Jie Li, ... Yanzhi Song in AAPS PharmSciTech
    Article 04 June 2024
  20. Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer

    Background

    Several studies have shown that the TGF-β signaling pathway plays a critical role in colorectal cancer (CRC) pathogenesis. The aim of the...

    Maryam Moradi Binabaj, Fereshteh Asgharzadeh, ... Seyed Mahdi Hassanian in DARU Journal of Pharmaceutical Sciences
    Article 23 September 2023
Did you find what you were looking for? Share feedback.